Patent suit against Osteometer (Denmark) withdrawn:
This article was originally published in Clinica
Executive Summary
Ostex International (US) has withdrawn legal action against Osteometer (Denmark) in the Netherlands in which it alleged patent infringement of technology incorporated in the bone resorption assay, Osteomark (see Clinica No 663, p 15). Osteometer is working with Cortecs on the development of a doctor's office test for osteoporosis using Osteometer's CrossLaps technology which was the subject of the legal action. Cortecs aims to launch the test this calendar year, says president Dr Michael Flynn.